- Abstract Number: 126
Cyclophosphamide as Rescue Therapy for Kawasaki Disease with Peripheral Vascular Disease: A Single Center Experience
- Abstract Number: 141
Cyclophosphamide Use in Treatment of Refractory Kawasaki Disease: A Single Center Case Series of 10 Patients and Literature Review
- Abstract Number: 107
Defining the Prevalence of Depression and Anxiety Symptoms in Adolescents with Juvenile Idiopathic Arthritis
- Abstract Number: 007
Dense Genotyping of Immunologic Loci Identifies CXCR4 as a Novel Susceptibility Locus for Systemic Juvenile Idiopathic Arthritis
- Abstract Number: 171
Development and Acceptability of an Adolescent Self-management Program for Juvenile Idiopathic Arthritis
- Abstract Number: 068
Development of CARRA Consensus Treatment Plans for Severe ANCA-associated Vasculitis – Final CARRA-wide Consensus
- Abstract Number: 151
Differences in Chromatin Architecture Between Treatment-Naïve Pediatric and Adult Lupus Patients
- Abstract Number: 073
Differences in Clinical Presentation Between Israeli and United States Children with Juvenile Spondyloarthritis
- Abstract Number: 055
Differential Analysis of Serum and Urine S100 Proteins in Juvenile-onset Systemic Lupus Erythematosus (jSLE)
- Abstract Number: 105
Discovering the Implications of Adiposity in Juvenile Dermatomyositis
- Abstract Number: 127
Disease Characteristics and Medication Utilization in Lupus Nephritis Associated with Childhood-Onset Systemic Lupus Erythematosus
- Abstract Number: 100
Does Anakinra Dampen Neuronal Damage in Children with Febrile-Infection Related Epilepsy Syndrome (FIRES): A Single Center Review of Neuroimaging
- Abstract Number: 153
Double Negative T Cells in Juvenile Dermatomyositis
- Abstract Number: 098
Early Treatment with Anakinra in Systemic Juvenile Idiopathic Arthritis
- Abstract Number: 177
Educational Outcomes in a Young-Adult Cohort of Patients with Childhood Onset Systemic Lupus Erythematosus (SLE)
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 13
- Next Page »